X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

Meta Unveils its First Open AI Model That Can Process Images

itsecuritynews.info - 30/Sep 14:32

  Meta has released new versions of its renowned open source AI model Llama, including small and medium-sized models capable of running workloads on...

Sorry! Image not available at this time

Meta Unveils its First Open AI Model That Can Process Images

itsecuritynews.info - 30/Sep 14:32

  Meta has released new versions of its renowned open source AI model Llama, including small and medium-sized models capable of running workloads on...

Sorry! Image not available at this time

TECNO Launches First AI-Powered Ecosystem, Revolutionizing African Tech Experience

femmehub.com - 02/Oct 10:01

TECNO today announced the launch of its first-ever AI-powered ecosystem. Unveiled at an exclusive event, the ecosystem showcases a groundbreaking...

Sorry! Image not available at this time

Huawei Connect 2024: Amplifying Intelligence and Driving AI-Powered Transformation

techxmedia.com  - 20/Sep 13:28

Huawei Connect 2024 kicked off its 3-day event in Shanghai, […]

Sorry! Image not available at this time

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

mideastnews.ae  - 02/Oct 12:18

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling...

Sorry! Image not available at this time

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

emiratesnewswire.com  - 02/Oct 12:18

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling...

Sorry! Image not available at this time

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

varabnewsexpress.ae  - 02/Oct 12:18

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling...

Sorry! Image not available at this time

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

emiratesnewswire.ae - 02/Oct 12:18

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling...